NIH Exploratory/Developmental Research Grant Program (Parent R21)

Scope Note

The R21 grant mechanism is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development. The NIH has standardized the Exploratory/Developmental Grant (R21) application characteristics, requirements, preparation, and review procedures in order to accommodate investigator-initiated (unsolicited) grant applications. See the NIH Exploratory/Developmental Research Grant Award (R21) page for more information.

There is also a list of ICs that do not accept unsolicited R21 applications. Non-participating ICs might solicit other R21 applications using Requests for Applications (RFAs) or Program Announcements (PAs) to meet specific program needs. Information about such initiatives can be obtained in the NIH Guide for Grants and Contracts at /grants/guide/index.html and by consulting with NIH staff. In some cases those announcements may specify different application characteristics, review criteria, and receipt dates.

PA-16-161

Release Date: March 31, 2016
Expiration Date: May 8, 2019

Contacts and Special Interests

R21 Participating Institutes and Centers

NIH Institutes and Centers that accept Investigator-Initiated R21 applications in response to the Parent R21 Announcement - (PA-16-161): NCCIH, NEI, NHGRI, NIA, NIAAA, NIAID, NIAMSNIDA, NIDCD, NIDCR, NIEHS, NIMH, NIMHDNINR and NLM.

R21 Non-Participating Institutes and Centers

NIH Institutes and Centers that DO NOT ACCEPT R21 applications in response to the Parent R21 Announcement but ONLY accept R21 applications in response to their specific funding opportunity announcements: FIC, NCI, NCATS, NHLBI, NIDDK, NIGMS, NINDS, and ORIP.

NIH Institute and Center Contacts and Scientific Research Areas of Interest

NIH Institute/Center Scientific/Research Contact
Scientific Research Areas of Interest
Financial or Grants
Management Contact
National Center for Complementary and Integrative Health (NCCIH)

NCCIH Program contacts, listed by program portfolio, may be found at:
http://NCCIH.nih.gov/grants/contact/

The National Center for Complementary and Integrative Health (NCCIH) will accept investigator-initiated exploratory/developmental projects (R21) for all program areas supported by the Center. Potential applicants are encouraged to view Research Funding Priorities at http://NCCIH.nih.gov/grants/priorities/.

Shelley Carow
Phone: 301-594 3788
FAX: 301-480-1552
Email: CarowS@MAIL.NIH.GOV
National Human Genome Research Institute (NHGRI)

Bettie J. Graham, Ph.D.
Phone: 301-496-7531
FAX: 301-480-2770
Email: Bettie_graham@nih.gov

The National Human Genome Research Institute (NHGRI) will accept investigator-initiated exploratory/developmental projects (R21) for all program areas supported by the Institute. NHGRI uses the R21 mechanism for pilot projects or feasibility studies to develop new, and/or to significantly improve existing genomics and proteomics technologies and to encourage high risk/potential high payoff research. Potential applicants are encouraged to review the Institute's goals in its latest program planning document, "A Vision for the Future of Genomics Research," http://www.genome.gov/11007524.

Deanna L.Ingersoll
Grants Administration Branch
Phone: (301) 435-7858
E-mail: Deanna.Ingersoll@nih.gov
National Eye Institute (NEI)

Dr. Ellen Liberman
Phone: 301-451-2020
Email: esl@nei.nih.gov

The National Eye Institute (NEI) will accept investigator-initiated exploratory/developmental projects (R21) for all program areas supported by the Institute.

For information regarding specific programmatic priorities, see http://www.nei.nih.gov. The NEI also solicits R21 applications for a specialized program which has particular research objectives and application and review procedures. Information regarding the NEI Research Grant for Secondary Data Analysis is available on our website.

William W. Darby
Phone: 301-451-2020
FAX: 301-496-0528
Email:  darbyw@mail.nih.gov 
National Institute on Aging (NIA)

Sanoj Suneja, Ph.D.
Phone: 301-402-7710
FAX: 301-402-2945
Email: sunejas@mail.nih.gov 

The National Institute on Aging (NIA) will accept investigator-initiated exploratory/developmental projects (R21) for all program areas supported by the Institute.

For information regarding specific programmatic priorities, see Research Projects.

Traci Lafferty
Phone: 301-496-8987
FAX: 301-402-3672
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Division of Epidemiology and Prevention Research
Gregory Bloss
Phone: 301-443-3865
FAX:301-443-8614
E-mail: gbloss@mail.nih.gov

Division of Medications Development Research 
Joanne B. Fertig, Ph.D.
Phone: 301-443-0635
FAX:301-443-8774
E-mail:  jfertig@mail.nih.gov

Division of Metabolism and Health Effects 
Dale Hereld, M.D., Ph.D.
Phone: 301-443-0912
FAX:301-594-0673
E-mail:  hereldd@mail.nih.gov

Division of Neuroscience and Behavior
Lindsey Grandison, Ph.D.
Phone 301-443-0606
FAX: 301-443-1650 
E-mail:  lgrandis@mail.nih.gov 

The National Institute on Alcohol Abuse and Alcoholism (NIAAA) will accept investigator-initiated exploratory/developmental projects (R21) for all program areas supported by the Institute, particularly those defined as NIAAA special emphasis areas.  The Institute's mission statement, extramural research program descriptions, list of special emphasis areas, active program announcements may be found at the NIAAA web site: http://www.niaaa.nih.gov.

The NIAAA R21 program provides limited support for exploring the feasibility of innovative or creative research questions within the research interests of the NIAAA. This includes basic and applied research on biochemical, physiological, genetic, and behavioral mechanisms leading to pathological drinking behavior; mechanisms of alcohol-induced organ damage, including fetal injury; and clinical, behavioral, and epidemiological approaches to more effective diagnosis, prevention, and treatment of alcoholism, alcohol abuse and alcohol-related problems. While applications may involve a wide variety of biomedical, behavioral, clinical, sociocultural, or other disciplines, relevance to the mission of the NIAAA must be clear.

To obtain more information about existing NIAAA program areas and the corresponding program administrators for R21 awards, please refer to the NIAAA extramural website.

Judy Fox
Phone: 301-443-4704
FAX: 301-443-3891
Email: jfox@mail.nih.gov 
National Institute of Allergy and Infectious Diseases (NIAID)

Conrad Mallia, Ph.D.
Division of Allergy, Immunology, and Transplantation (DAIT)
Phone: 240-627-3491
E-mail: cmallia@niaid.nih.gov​

Madelon Halula, PhD
Division of AIDS (DAIDS)
Phone: 240-292-4843    
Email: mhalula@niaid.nih.gov

Clayton Huntley, PhD
Division of Microbiology and Infectious Diseases (DMID)
Phone:  240-627-3279
Email: chuntley@niaid.nih.gov

For general information about NIAID support of R03 applications, e-mail NIAIDReceiptReferral@niaid.nih.gov

The National Institute of Allergy and Infectious Diseases (NIAID) will accept investigator-initiated exploratory/developmental projects (R21) for all program areas supported by the Institute, but will not accept R21 applications that include clinical trials.

For more information on NIAID’s policy regarding clinical trials, see /grants/guide/notice-files/NOT-AI-16-084.html

For information on NIAID R21 research opportunities in Biodefense, please see http://www.niaid.nih.gov/topics/BiodefenseRelated/Biodefense/research/.

Ann Devine
Phone: (240) 669-2988
FAX: 301-493-0597
Email: adevine@niaid.nih.gov
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) For information regarding NIAMS supported scientific areas/programs and contacts, please see: https://www.niams.nih.gov/grants-funding/supported-scientific-areas. Andrew Jones 
Phone: 301-435-0610
Email: jonesan@mail.nih.gov
National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Randy King, Ph.D.
Tel: 301-451-0707
Fax: 301-480-1614
E-mail: randy.king@nih.gov

The NIBIB no longer participates in PA-16-161, “NIH Exploratory/Developmental Research Grant Program (Parent R21)” or in PA-16-040 “Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21)s. NIBIB will continue to accept R21 applications under separate NIBIB Program Announcements

For more information see https://www.nibib.nih.gov/research-funding/exploratorydevelopmental-grant-program-r21

 
National Institute of Dental and Craniofacial Research (NIDCR)

Contact information can be found at: http://www.nidcr.nih.gov/Research/DER/ContactRA.htm

Integrative Biology and Infectious Diseases Branch
Nadya Lumelsky, Ph.D.
Phone: 301-594-7703
Email: nadyal@nidcr.nih.gov

Center for Clinical Research
Dena Fischer, DDS, MSD, MS
Phone: 301-594-4876
Email: fischerdj@nidcr.nih.gov

Translational Genomics Research Branch
Kathryn Stein, Ph.D.
Phone: 301-827-4653
Email: steink@nidcr.nih.gov
 

Behavioral and Social Science Research Branch
Melissa Riddle, Ph.D.
Phone:  301-451-3888
Email: riddleme@nidcr.nih.gov

For current funding opportunities and contacts, see https://www.nidcr.nih.gov/grantsandfunding/FundingOpportunityAnnouncements/ByTopic.htm

Dede Rutberg, MBA
Chief Grants Management Officer
Phone: 301-594-4798
FAX: 301-480-3562
Email:rutbergd@mail.nih.gov
National Institute on Drug Abuse (NIDA)

Tracy Waldeck, Ph.D.
Phone: 301-827-5844
Email: tracy.waldeck@nih.gov

The National Institute on Drug Abuse (NIDA) The National Institute on Drug Abuse (NIDA) will accept investigator-initiated exploratory/developmental projects (R21) for all program areas supported by the Institute.

NIDA uses the R21 mechanism to provide support for projects in the early stages of developing or testing innovative ideas in any area relevant to the mission of the Institute. Since this mechanism is intended to enable an investigator to receive support for the early and conceptual stages of an innovative research question or approach, preliminary data specific to the proposed project are not expected.  Novel scientific ideas, model systems, tools, agents, targets and technologies that have the potential to advance research in substantial ways and relevant to the mission of NIDA are appropriate for this mechanism. Long-term projects or projects designed to establish knowledge in a well-established area should not use the R21mechanism.

Pam Fleming
Phone: 301-253-8729
FAX: 301-594-6849
Email: pfleming@nida.nih.gov
National Institute on Deafness and Other Communication Disorders (NIDCD)

Nancy L. Freeman, Ph.D.
Phone: 301-402-3458
FAX: 301- 402-6251
Email: FreemanN@mail.NIH.gov

For a list of scientific staff, also see Staff Contacts.

The National Institute on Deafness and Other Communication Disorders (NIDCD) uses the Exploratory/Developmental Research Grant Award (R21) to support the development of novel ideas, technologies, or methodologies at an early stage of development which have the potential to break new ground or extend toward new directions or applications.

The NIDCD supports basic and clinical biomedical and behavioral research in the communication sciences of hearing, balance, smell, taste, voice, speech and language. The proposed research must be focused on one or more of these scientific mission areas.

Christopher Myers
Phone:  301-435-0713
FAX: 301-402-1758
Email: myersc@mail.nih.gov
National Institute of Environmental Health Sciences (NIEHS)

Daniel Shaughnessy, Ph.D. 
Phone: 984-287-3321
FAX: 919-316-4606
Email: shaughn1@niehs.nih.gov

The National Institute of Environmental Health Sciences (NIEHS) will accept investigator-initiated research projects using the R21 mechanism for all areas of environmental health science research; particularly those defined as NIEHS special emphasis areas. Details on these areas can be found at http://www.niehs.nih.gov/research/supported/programs/index.cfm.

To obtain more information about existing NIEHS program areas and their corresponding program administrators, see http://www.niehs.nih.gov/funding/grants/contacts.cfm 

Pamela Clark
Phone:  984-287-3246
Email:  evans3@niehs.nih.gov
National Institute of Mental Health (NIMH)

NIMH Program Staff contacts Inquiries may be directed to NIMHReferral@mail.nih.gov. Also, see Division web pages (below)
 

The National Institute of Mental Health (NIMH) will accept investigator-initiated exploratory/developmental projects (R21) for all program areas supported by the Institute:

Examples of the types of projects supported by NIMH through the R21 program include: pilot or feasibility studies; development of research methodology; high risk studies; development of new research technology; small-scale, self-contained projects; and analysis of existing data sets.

Rebecca Claycamp, M.S., C.R.A.
Phone: 301-443-2811
FAX: 301-480-1956
Email: rclaycam@mail.nih.gov
National Institute on Minority Health and Health Disparities (NIMHD)

Rina Das, PhD
Phone: 301-496-3996
Email: dasr2@mail.nih.gov

The National Institute on Minority Health and Health Disparities (NIMHD) will accept investigator-initiated exploratory/developmental projects (R21) for all program areas supported by the Institute. For further information on NIMHD investigator-initiated minority health and health disparities research, please see http://www.nimhd.nih.gov/programs/extra/iir.pdf.

Priscilla Grant, JD
Phone: 301-594-8412
Email:  pg38h@nih.gov
National Institute of Nursing Research (NINR) The National Institute of Nursing Research (NINR) will accept investigator-initiated R21 applications for exploratory/developmental projects in areas that are mission-relevant (http://www.ninr.nih.gov/AboutNINR/NINRMissionandStrategicPlan/). This includes potentially high-risk/high payoff projects in the early stages of development and projects having innovative scientific ideas. Please contact the NINR Program Director listed in the area of science in which you are interested. NINR Program Staff contacts may be found at: http://www.ninr.nih.gov/ResearchAndFunding/
DEA/OEP/AreasofscienceFile.htm
Brian Albertini
Phone: 301-594-6869
FAX: 301-402-4502
Email: albertib@mail.nih.gov
National Library of Medicine (NLM) 

Clinical and Public Health Informatics
Dr. Hua-Chuan Sim
Phone: 301.594.4882
FAX: 301.402.2952 
Email: Simh@mail.nih.gov

Bioinformatics and Translational Informatics
Dr. Jane Ye
Phone: 301.594.4882
FAX: 301.402.2952 
Email: yej@mail.nih.gov

Consumer Informatics 
Dr. Alan VanBiervliet
Phone: 301.594.4882
Fax: 301.402.2952
Email: alan.vanbiervliet@nih.gov

The National Library of Medicine (NLM) will accept investigator-initiated R21 applications that explore new areas in its mission relevant areas, which include data science, healthcare/clinical informatics, public health informatics, translational informatics, bioinformatics, consumer health informatics and information sciences. NLM is particularly interested in highly innovative, high-risk/high impact biomedical informatics projects. The range and scope of NLM's research interests is described at http://www.nlm.nih.gov/ep/GrantExDev.html.

Dwight Mowery
Phone: 301-496-4221
FAX 301-402-0421
Email:  moweryd@mail.nih.gov

NIH Institutes and Centers that DO NOT ACCEPT R21 applications in response to the Parent R21 Announcement but ONLY accept R21 applications in response to their specific funding opportunity announcements:  FIC, NCI, NCATS, NIMHD, NHLBI, NIDDK, NIGMSNINDS, and ORIP.

NIH Institute/Center Scientific/Research Contact
Scientific Research Areas of Interest
Financial or Grants Management Contact
Fogarty International Center (FIC) The Fogarty International Center (FIC) will not accept investigator initiated R21 applications in response to the Parent R21 FOA. The FIC will use the R21 mechanism only when specified by specific PAs or RFAs that it has initiated or in which it participates. Investigators are encouraged to contact an FIC Program Officer staff within the Division of International Training and Research for assistance with submitting a grant application. Please consult our website, Fogarty Extramural Program for information regarding programmatic structure and priorities. None
National Cancer Institute (NCI) The National Cancer Institute (NCI) will not accept R21 applications in response to the Parent R21 Announcement. NCI will use the R21 mechanism only when specified by specific PAs or RFAs that it has initiated or in which it participates. The currently active announcements are listed on the NCI website at: Extramural Funding Opportunities. None
National Center for Advancing Translational Sciences (NCATS) National Center for Advancing Translational Sciences (NCATS) will not accept R21 applications in response to the Parent R21 Announcement. NCATS will use the R21 mechanism only when specified by specific PAs or RFAs that it has initiated or in which it participates. None
The National Heart, Lung, and Blood Institute (NHLBI)  The National Heart, Lung, and Blood Institute (NHLBI) will not accept R21 applications in response to the Parent R21 Announcement. NHLBI will use the R21 mechanism only when specified by specific PAs or RFAs that it has initiated or in which it participates. None
National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) The National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) will not accept R21 applications in response to the Parent R21 Announcement. NIDDK will use the R21 mechanism only when specified by specific PAs or RFAs that it has initiated or in which it participates. View R21 FOAs in which NIDDK participates. None
National Institute of Neurological Disorders and Stroke (NINDS) The National Institute of Neurological Disorders and Stroke (NINDS) will not accept R21 applications in response to the Parent R21 Announcement. NINDS will use the R21 mechanism only when specified by specific PAs or RFAs that it has initiated or in which it participates. The currently active announcements are listed on the NINDS website at: Research Project Grants  
The National Institute of General Medical Sciences (NIGMS)  The National Institute of General Medical Sciences (NIGMS) will not accept R21 applications in response to the Parent R21 Announcement. The NIGMS will use the R21 mechanism only when specified by specific PAs or RFAs that it has initiated or in which it participates. A listing of these is available in the NIGMS R21 Participation Statement. None
Office of Research Infrastructure Programs (ORIP) The Office of Research Infrastructure Programs (ORIP) will not accept R21 applications in response to the Parent R21 Announcement. ORIP will use the R21 mechanism only when specified by specific PAs or RFAs that it has initiated or in which it participates. None

This page last updated on: August 23, 2024
For technical issues E-mail OER Webmaster